Introduction {#sec1-1}
============

Diabetic retinopathy (DR) and age-related macular degeneration (AMD) are the fifth and third most common causes of moderate-to-severe visual impairment worldwide.\[[@ref1]\] As of 2010, there are an estimated 127 million cases of DR,\[[@ref2]\] and as of 2014, 170 million cases of AMD.\[[@ref3]\] These numbers are projected to rise to 191 million,\[[@ref2]\] and 243 million,\[[@ref3]\] respectively, by the year 2030.

The international diabetes foundation estimates that the number of Africans with diabetes will increase by 162% from 15.9 million in 2017 to 41.6 million in 2045.\[[@ref4]\] With between 30.2% and 31.6% of African diabetics experiencing DR, there is projected to be an increase of approximately eight million African individuals experiencing DR between now and 2045.\[[@ref5]\] Furthermore, Africa is the region with the highest percentage of undiagnosed diabetics in the world, with approximately 70% of people with diabetes unaware of their condition.\[[@ref4]\] Consequently, the prevalence of severe DR in Africans has been reported to be 52% of DR cases, significantly higher than in individuals from other regions.\[[@ref6]\] Similarly, the number of Africans with AMD is projected to increase by 105% from 19.0 million in 2018 to 39.1 million by 2040.\[[@ref3]\]

Unfortunately, in the developing world, and particularly in Sub-Saharan Africa, there are problems with poor patient attendance in clinics, inadequate or even nonexistent referral systems to ophthalmic services, poor record-keeping, nonexistent systematic screening programs, and inadequate access to imaging and therapeutic technology.\[[@ref5]\] These additional barriers add another degree of complexity when trying to treat AMD and DR in these regions.

Teleretina (TR) refers to the use of telecommunication and technology to evaluate and treat patients with retinal diseases at a distance. TR programs allow for a diagnosis to be made most commonly through the use of stereoscopic photography, examining for clinical signs of DR and AMD.\[[@ref7]\] TR programs have been shown to be effective in reducing office visits,\[[@ref8]\] as well as in increasing screening rates and access to recommended eye care in those with DR and AMD.\[[@ref9][@ref10]\] Early detection and treatment of retinal abnormalities is critical in preventing vision loss in those with DR and AMD,\[[@ref11][@ref12]\] and TR has been shown to be an effective early form of screening.\[[@ref12][@ref13]\] Despite this, more research is needed to evaluate the efficacy and reliability of TR on a global scale.\[[@ref14]\]

The aim of this study was to compare the efficacy of a web-based TR assessment with an in-person clinical slit lamp examination to screen for DR and AMD among diabetic patients in a rural African district.

Materials and Methods {#sec1-2}
=====================

Ethics approval {#sec2-1}
---------------

Ethics approval was obtained from the Aga Khan University East Africa Research Committee as part of the Faculty of Health Sciences Medical College in Nairobi, Kenya. The investigation was carried out following the tenets of the Declaration of Helsinki.

Patient selection {#sec2-2}
-----------------

The study was carried out in the Muranga District Hospital diabetes and ophthalmology clinics. A precision-based method was used to calculate the appropriate sample size. All patients above the age of 30 years who were capable of giving informed consent and who attended the Muranga Hospital Diabetic Clinic between August and October 2011 were included in the study. Individuals under the age of 30 years, with ocular anatomy (natural or traumatic) inhibiting adequate fundus photography, or with physical deformities that inhibited proper positioning for fundus photography and visual field examination were excluded. Patients were also excluded at the discretion of the nurses in cases with the potential for aggressive behavior or violence. Finally, blurry fundus photos that were not conducive to TR assessment were excluded from the study.

Patient prescreening {#sec2-3}
--------------------

After obtaining informed consent, patients underwent both a general medical and an ocular history by a trained ophthalmic assistant (OA) using a predetermined form \[[Appendix](#APP1){ref-type="app"}\]. The OAs were trained to take thorough histories before the study at the Aga Khan University Hospital in Nairobi. The initial ocular assessment conducted by the OAs included visual acuity, external ocular exam with a penlight, intraocular pressures with a Tonopen (Reichert Technologies, Depew, NY, USA), frequency doubling technology (FDT) visual field screening perimetry (screening C-20 program), and fundus photography \[[Appendix](#APP1){ref-type="app"}\]. A photograph of the visual field test printout was digitally uploaded. Stereo images of fundus were acquired following pupil dilation with 1% tropicamide. All fundus photos were obtained with a Topcon 777 (Topcon Corp., Tokyo, Japan) three field fundus camera at 45°. Each 172 MB (24 bits/pixel) file was 16:1 compressed to a 1.1 MB (1.5 bits/pixel) JPEG image. The OAs uploaded the history form, the examination form, the color photographs, and the results of the visual field testing onto a secure patient data website operated by secure diagnostic imaging (SDI) based at the University of Alberta (www.teleophthalmology.com). The software to date has already been validated for DR and utilized for Teleretinal screening at the University of Alberta, Canada.\[[@ref7][@ref15]\] An internet modem from Safaricom Limited was used to access the website. Patients were subjected to both slit lamp (see protocol \#1 below) and teleophthalmology examination (see protocol \#2 below), and results were compared.\[INLINE:1\]

Protocol \#1 slit lamp examination {#sec2-4}
----------------------------------

Following prescreening, each patient was seen by a comprehensive ophthalmologist based in the district. The ophthalmologist reviewed the history form, the examination form, and the FDT printout. They subsequently completed a dilated fundus exam to diagnose and grade the DR and/or AMD using the predetermined form \[[Appendix](#APP1){ref-type="app"}\]. Lens opacity was recorded based on the lens opacities classification system III classification.\[[@ref16]\] During the slit lamp examination, a 90D lens was used to examine the optic nerve and macula to record any DR and/or AMD features. DR was graded based on the early treatment diabetic retinopathy study classification and AMD based on age-related eye disease study grading scale \[[Appendix](#APP1){ref-type="app"}\].

Protocol \#2 remote teleopthalmology investigation {#sec2-5}
--------------------------------------------------

After uploading the data onto the SDI website, a remote ophthalmologist reviewed the history form, the examination form, the color photographs, and the visual fields. The ophthalmologist viewed the fundus photos in three-dimensions and indicated any observed microaneurysms, venous beading, intraretinal microvascular abnormality, drusen size/area, pigmentary changes, geographic atrophy and/or macular edema. [Figure 1](#F1){ref-type="fig"} demonstrates a nurse taking fundus photographs and an ophthalmologist grading the teleophthalmology images. A positive DR and/or AMD diagnosis in the setting of TR analysis was based on a synthesis of history and retinal examination. For a summary of the criteria used to diagnose the DR and AMD, refer to the appendix.

![(a) Dr. Dan Kiage seen grading teleophthalmology images wearing LCD shutter goggles. The fundus image appears on one screen while the grading form appears on a separate screen. (b) Nurse Florence taking a fundus photograph in Muranga](MEAJO-27-91-g001){#F1}

Blinding protocol {#sec2-6}
-----------------

To ensure a fair comparison, the district comprehensive ophthalmologist doing the in-person fundus exam and the ophthalmologist performing the remote grading were blinded from each other\'s findings. The information obtained from the clinical examination and the SDI program software was entered into Microsoft Excel and SPSS 11.0 (IBM Corp, New York, NY, USA) for analysis and comparison.

Statistical analysis {#sec2-7}
--------------------

Predictive values were used to compare the results from the TR assessment and the clinical slit lamp examination. The kappa (κ) statistic was calculated using individual eyes as the unit of analysis to analyze the reproducibility of the measurements and diagnoses between the two assessments. To reduce the effects of intra-patient clustering introduced by using the results from both eyes for the slit lamp and TR protocols, the standard error was adjusted in the random-effects model using the bootstrapping method described by Landis and Koch.\[[@ref17]\] For all other analyses, the exact agreement was used. Photographs deemed ungradable were excluded from the κ analysis. κ values \>0.81 illustrate almost perfect strength of agreement, values between 0.61 and 0.80 illustrate substantial agreement, values between 0.41 and 0.60 illustrate moderate agreement, values between 0.21 and 0.40 illustrate fair agreement, and values between 0 and 0.20 illustrate slight agreement.\[[@ref17]\]

Sample size {#sec2-8}
-----------

Given that the literature has reported rates of DR and AMD among African Diabetics to be 31%,\[[@ref18]\] and 1.3%,\[[@ref19]\] respectively, a sample size of at least 329 eyes was required (α = 0.05, d = 0.05).

Results {#sec1-3}
=======

Study population analysis {#sec2-9}
-------------------------

The study included 314 patients and 628 eyes, thereby fulfilling the sample size requirement for this cross-sectional analysis. Of note, the mean age of included patients was 62 ± 11.6 years; the median number of years that patients had been diagnosed with diabetes mellitus was five. In addition, 60% of patients had a history of hypertension, and 5% had a history of blindness \[[Table 1](#T1){ref-type="table"}\]. All 314 patients completed the clinical examination, whereas eight patients did not complete the entire TR exam. Six individuals did not complete the TR portion of the examination and two were missing clinical data. Six hundred and twelve fundus photos were taken, 74 (12%) of which were deemed ungradable. Thirty-nine were ungradable due to media opacities: 22 cataracts, 10 corneal opacities, and 7 postcataract posterior capsular opacities \[Appendi × 1\], whereas the other 35 cases were ungradable due to poor pupil dilation, unsatisfactory photographs, or uncooperative patients. Ninety-four cases of DR and 13 cases of AMD were identified. [Figure 2](#F2){ref-type="fig"} demonstrates fundus photographs taken in this investigation and their associated retinal pathologies.

###### 

Patient population overview

  General characteristics                          Specific Item       Value (percentage of total)
  ------------------------------------------------ ------------------- -----------------------------
  Age (years)                                      Mean±SD             62±11.6
  SD                                               11.6                
  Median                                           63                  
  Range                                            33-91               
  Gender                                           Male                124 (40)
  Female                                           187 (60)            
  Missing information                              3                   
  Duration of previous diabetes mellitus (years)   Median              5
  Range                                            0-44                
  Presence of comorbidities and risk factors       Hypertension        188 (60)
  Heart disease                                    11 (4)              
  Asthma                                           15 (5)              
  Other systemic diseases and complications        20 (6)              
  Alcohol consumption                              8 (3)               
  Cigarette smoking                                2 (1)               
  Past ocular history                              Prior eye surgery   18 (6)
  Known glaucoma                                   11 (4)              
  Using glaucoma medication(s)                     17 (5)              
  Family history of blindness                      15 (5)              
  Mean intraocular pressure (mmHg)                 22±8.5              
  Total patient size                               Total               314 (100)

SD: Standard deviation

![Fundus photographs demonstrating a variety of retinal pathologies. (a) Microaneurysms (ETDRS level 20) (b) CSME (ETDRS level 35D). (c) Moderate NPDR (ETDRS level 35F) (d) Moderate NPDR (ETDRS level 43B) e) PDR (ETDRS level 65C) f) PDR (ETDRS level 65B) ETDRS: Early treatment diabetic retinopathy study, CSME: Clinically significant macular edema, NPRDR: Non-proliferative diabetic retinopathy, PDR: Proliferative diabetic retinopathy](MEAJO-27-91-g002){#F2}

Comparison of the ability to diagnose diabetic retinopathy and age-related macular degeneration {#sec2-10}
-----------------------------------------------------------------------------------------------

The diagnosis of DR and AMD was based on a synthesis of history and retinal examination. When comparing the ability to diagnose these two conditions, the κ score of agreement between the TR analysis and the clinical slit lamp examination was 0.27 for DR (95% confidence interval \[CI\]: 0.21--0.33), and 0.23 for AMD (95% CI: 0.001--0.47).

Thereby these results indicate a fair agreement between the two methods for the diagnosis of DR and AMD \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparison of the agreement in diagnosis between teleretina and clinical slit lamp examination in the analysis of both patient eyes

  Assessment                                           κ      95% CI (κ)
  ---------------------------------------------------- ------ ------------
  Overall diabetic retinopathy diagnosis               0.27   0.21-0.33
  Overall age-related macular degeneration diagnosis   0.23   0.001-0.47

CI: Confidence interval

Relative to the clinical slit lamp examination, TR has a 76.6% (95% CI: 62.8--86.4) sensitivity, and a 96.9% (95% CI: 94.7--98.2) specificity for diagnosing DR and a 23.1% (95% CI: 5.0--53.8) sensitivity, and a 98.48% (95% CI: 97.0--99.3) specificity for diagnosing AMD; a diagnosis of DR using TR assessment had a 75.0% (95% CI: 61.2--85.1) positive predictive value and a 97.2% (95% CI: 95.0--98.4) negative predictive value. A diagnosis of AMD carried a 27.3% (95% CI: 10.1--55.6) positive predictive value and 98.1% (95% CI: 97.5--98.6) negative predictive value. The likelihood ratio of a positive diagnosis of DR with TR relative to clinical slit lamp examination was 25.1 (95% CI: 14.1--44.8), and the likelihood ratio of a negative diagnosis was 0.2 (95% CI: 0.2). For the AMD assessment, the likelihood ratio of a positive diagnosis was 15.1 (95% CI: 4.5--50.3) and the likelihood ratio of a negative diagnosis was 0.8 (95% CI: 0.6--1.1) \[[Table 3](#T3){ref-type="table"}\]. The prevalence of DR and AMD within our sample of African diabetics analyzed by clinical slit lamp examination was 10.7% and 2.4%, respectively; the prevalence of DR and AMD by TR assessment was 10.9% and 2.0%, respectively.

###### 

Ability of teleretina screening to diagnose diabetic retinopathy and age-related macular relative to the clinical slit lamp examination

  Characteristic   Diabetic retinopathy   Age-related macular degeneration          
  ---------------- ---------------------- ---------------------------------- ------ -----------
  Sensitivity      76.6                   62.8-86.4                          23.1   5.0-53.8
  Specificity      96.9                   94.7-98.2                          98.5   97.0-99.3
  PPV              75.0                   61.2-85.1                          27.3   10.1-55.6
  NPV              97.2                   95.0-98.4                          98.1   97.5-98.6
  LR+              25.1                   14.1-44.8                          15.1   4.5-50.7
  LR−              0.2                    0.1-0.4                            0.8    0.6-1.1

PPV: Positive predictive value, NPV: Negative predictive value, LR+: Likelihood ratio of the positive test, LR−: Likelihood ratio of negative test

Discussion {#sec1-4}
==========

In this investigation, TR assessments yielded a fair agreement with clinical slit lamp examinations in their ability to diagnose DR and AMD. A positive diagnose via TR carried a 75.0% and 27.3% positive predictive value and a negative diagnosis carried a 97.2% and 98.1% negative predictive value for DR and AMD respectively relative to a clinical examination.

TR screening has shown much promise in both rural and in inner-city settings to deliver more efficient and effective healthcare to patients.\[[@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref20][@ref21]\] Irrespective of geographical barriers, patients have limited access to appropriate eye care, leading to a delay in diagnosis and subsequent treatment of retinal diseases.\[[@ref5][@ref22]\] TR assessments have shown to be effective in combatting this issue, highlighted by one study demonstrating a six-fold increase in the rate of retinal examinations through TR when compared to usual care.\[[@ref20]\] Furthermore, previous research suggests, that with strategic workflow planning, TR screening can be fiscally advantageous from a health systems perspective by avoiding unnecessary physician services, and from a patient perspective by reducing travel costs and the loss of income secondary to traveling to retinal specialists.\[[@ref23]\] This is exceptionally important when considering the immense financial constraints of treating ocular conditions in the developing world.\[[@ref22]\] Another important factor to consider is that patients welcome the prospect of TR assessments. One study examining patient satisfaction with TR screening for DR found that close to 99% of patients were satisfied with a TR system and that 95% of patients would actually prefer a TR screening to a conventional clinical face-to-face examination.\[[@ref24]\] Before TR approaches are fully adopted; however, they must prove to have a similar diagnostic ability to the current gold standards for evaluating retinal diseases. A recent literature review examining the feasibility of TR for DR and AMD found that as with the results of our investigation, the current literature tends to report a high specificity for TR screening for DR with specificities varying depending on the severity of the DR.\[[@ref23]\] Another systematic review and meta-analysis found similar results and calculated the pooled specificity of TR evaluations to exceed 90% and the pooled sensitivity to exceed 80%.\[[@ref25]\] There exists substantially less literature examining the role of TR evaluations for AMD. One hypothesized explanation for this trend is that until relatively recently, there was a lack of effective treatments for AMD.\[[@ref23]\] The literature review examining the feasibility of TR for DR and AMD reported a large range of sensitivity and specificity values for the accuracy of AMD diagnosis through TR screening. The results varied greatly depending on the technique used and on the signs that each study was examining for, underscoring the need for further standardized investigations in the future.\[[@ref23]\] As with our study, a concern expressed in this review were the frequency of ungradable digital images with the rates ranging from 0% to 14.9% of all fundus photographs.\[[@ref23]\]

The results of this investigation are encouraging for the future implementation of a TR screening program in Sub-Saharan Africa. We were able to obtain digital fundus photographs of at-risk patients for DR and AMD from a rural African district at minimum cost and discomfort to the patient. These photographs were then reviewed by a remote ophthalmologist. The methodology and screening system utilized in this investigation can be used for future research to build off of in the pursuit of providing high-quality healthcare in lower-resource settings, as well as to improve efficiency and resource allocation in urban centers.

There are, however, several limitations must be considered when interpreting the results of this investigation. First, 74 (12%) of the fundus photographs were deemed ungradable due to media opacities, poor pupil dilation, unsatisfactory photographs, or uncooperative patients. Thus, while a TR approach may increase patient access to ophthalmic care, poor quality information may limit its effectiveness. In cases in which an appropriate clarity of photograph was achieved, factors such as differences in physician training or variations in the grading approach may have limited the level of agreement. Finally, there are inherent drawbacks to any telemedicine screening program that should also be considered. Notably, a potentially diminished physician-patient relationship due to a reduction in the level of face-to-face encounters and a reduction in patients\' ability to ask questions.\[[@ref26]\]

We suggest that future investigations involve a larger patient population to better confirm the agreement between the two assessment techniques. We also suggest that in order to reduce the effects of inter-observer variation and of variable training by the assessors, that the same ophthalmologist, with adequate time lapse to reduce the effects of recall bias, completes the slit lamp examination and grades the images virtually.

Conclusion {#sec1-5}
==========

In conclusion, AMD and DR are major causes of visual impairment and blindness around the world. Given the ability to manage these conditions, and the detrimental consequences of progressing to the late stages of these diseases, much attention is given to the early detection and initiation of treatment in patients with a positive diagnosis. TR screening protocols have been proposed as a viable solution to improve patient access to specialist care, especially in rural areas where financial, structural, and cognitive barriers result in less than ideal healthcare delivery. Our investigation demonstrated a fair correlation between TR screening and traditional slit-lamp examination in the diagnosis of DR and AMD. Although further validation is needed, the TR approach provides a promising method to diagnose and treat DR and AMD.
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###### 

Case definitions for diabetic retinopathy and age-related macular degeneration

  -----------------------------------------------------
  DR: ETDRS classification   AMD: AREDS grading scale
  -------------------------- --------------------------
  None\                      Large drusen\
  CSME\                      Pigmentary changes
  Mild NPDR\                 
  Moderate NPDR\             
  Severe NPDR\               
  PDR\                       
  Retinal laser completed    

  -----------------------------------------------------

CSME: Clinically significant macular edema, NPDR: Nonproliferative diabetic retinopathy, PDR: Proliferative diabetic retinopathy, ETDRS: Early treatment diabetic retinopathy study, AREDS: Age-related eye disease study

###### 

Reasons for ungradable fundus photographs (*n*=74)

  Reason                                        Number of cases (percentage of total)
  --------------------------------------------- ---------------------------------------
  Media opacification                           
  Cataract                                      22 (4)
  Corneal opacity                               10 (2)
  Intraocular lens posterior capsular opacity   7 (1)
  Nonopacification\*                            35 (6)
  Total                                         74 (12)

\*Including: Dilation difficulty, poor quality photograph, uncooperative patient

###### 

History forms

  -------------------------------------------------------------------------------------------- ------------------------------------ ------------------------------------
  Date\_\_\_\_\_\_\_\_\_\_\_\_\                                                                                                     
  Name: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_, Project No: \_\_\_\_\_\_\_\_\_\_,\                                        
  DOB: \_\_\_\_\_\                                                                                                                  
  Male/female: \_\_\_\_\_\_                                                                                                         

  History                                                                                      RE                                   LE

  Known glaucoma                                                                               Yes/no                               Yes/no

  Current ocular meds                                                                                                               

  Eye surgery                                                                                  Trab/cataract - IOL/aphakia Others   Trab/Cataract - IOL/aphakia Others

  Family history of glaucoma                                                                                                        

   Systemic history                                                                                                                 

   Systemic medication                                                                                                              

   Duration of diabetes                                                                                                             

   Hypertension                                                                                Yes/no                               

   Heart disease                                                                               Yes/no                               

   Asthma                                                                                      Yes/no                               

   Alcohol consumption                                                                         Yes/no                               

   Cigarette smoking                                                                           Yes/no                               
  -------------------------------------------------------------------------------------------- ------------------------------------ ------------------------------------

###### 

Examination form

  -------------------------------------------------------------------------------------------------- ---------------------- ----------------------
  Date\_\_\_\_\_\_\_\_\_\_\_\_\                                                                                             
  Name: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_, Project No: \_\_\_\_\_\_\_\_\_\_,\                          
  DOB:\_\_\_\_\_\                                                                                                           
  Male/female: \_\_\_\_\_                                                                                                   

  Exam                                                                                               RE                     LE

  VA                                                                                                 SC/CC/PH               SC/CC/PH

  IOP by tonopen                                                                                                            

  FDT visual fields                                                                                                         

  photography                                                                                                               

  Ophthalmologists examination                                                                                              

  Cornea                                                                                                                    

  Lens status                                                                                        Cataract/IOL/aphakia   Cataract/IOL/aphakia

  If Cataract - type and grade                                                                                              

  Vertical CDR                                                                                                              

   Notch                                                                                             Yes/no                 Yes/no

   PPA                                                                                               Yes/no                 Yes/no

   Disc hemorrhage                                                                                   Yes/no                 Yes/no

   Visual fields defect                                                                              Yes/no                 Yes/no

   Glaucoma                                                                                          Category 0\            Category 0\
                                                                                                     Category 1\            Category 1\
                                                                                                     Category 2\            Category 2\
                                                                                                     Category 3\            Category 3\
                                                                                                     Glaucoma suspect       Glaucoma suspect

   Diabetic retinopathy                                                                              None\                  None\
                                                                                                     CSME\                  CSME\
                                                                                                     Mild NPDR\             Mild NPDR\
                                                                                                     Moderate NPDR\         Moderate NPDR\
                                                                                                     Severe NPDR\           Severe NPDR\
                                                                                                     PDR\                   PDR\
                                                                                                     Retinal Laser done     Retinal Laser done

   AMD                                                                                               Yes/no                 Yes/no

   Other fundus pathology (describe)                                                                                        
  -------------------------------------------------------------------------------------------------- ---------------------- ----------------------

CSME: Clinically significant macular edema, NPDR: Nonproliferative diabetic retinopathy, PDR: Proliferative diabetic retinopathy, ETDRS: Early treatment diabetic retinopathy study, AREDS: Age-related eye disease study

###### 

DR: ETDRS grading protocol. International clinical diabetic retinopathy disease severity scale

  ---------------------------------------------------------------------------------------------------
  Proposed disease severity level   Findings observable with dilated ophthalmoscopy
  --------------------------------- -----------------------------------------------------------------
  No apparent DR                    No abnormalities

  Mild nonproliferative DR          Micro aneurysms only

  Moderate nonproliferative DR      More than "mild" but less than "severe"

  Severe nonproliferative DR        Any of the following\
                                    20 or more intraretinal hemorrhages in 4 quadrants\
                                    Definite venous beading in 2 or more quadrants\
                                    Prominent IRMA in 1 or more quadrants and no neovascularization

  Proliferative DR                  1 or more of the following\
                                    Definite neovascularization\
                                    Preretinal or vitreous hemorrhage
  ---------------------------------------------------------------------------------------------------

IRMA: Intraretinal microvascular abnormalities, ETDRS: Early treatment diabetic retinopathy study

###### 

International clinical diabetic macular edema disease severity scale

  Proposed disease severity level                       Findings on dilated ophthalmoscopy
  ----------------------------------------------------- -------------------------------------------------------------------------------------------------------
  DME absent                                            No retinal thickening or hard exudates present in the posterior pole
  DME present                                           Some retinal thickening or hard exudates present in the posterior pole
  If DME is present, it can be categorized as follows   
  Proposed disease severity level                       Findings observable on dilated ophthalmoscopy\*
  Mild DME                                              Some retinal thickening or hard exudates in posterior pole but distant from the center of the macula
  Moderate DME                                          Retinal thickening or hard exudates approaching the center of the macula but not involving the center
  Severe DME                                            Retinal thickening or hard exudates involving the center of the macula

\*Hard exudates are a sign of current or previous macular edema. DME is defined as retinal thickening, and this requires a 3-dimensional assessment that is best performed through a dilated pupil examination using slit-lamp biomicroscopy with an accessory lens and/or stereo fundus photography. DME: Diabetic macular edema

**AMD: AREDS grading scale**
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